These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36669687)
1. Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia. Yoshino N; Kimura SI; Matsuoka A; Meno T; Ishikawa T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Misaki Y; Yoshimura K; Gomyo A; Okada Y; Tamaki M; Akahoshi Y; Kusuda M; Kameda K; Tanihara A; Wada H; Nakasone H; Kako S; Kanda Y J Infect Chemother; 2023 Apr; 29(4):384-390. PubMed ID: 36669687 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy. Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y Infect Dis (Lond); 2017 Oct; 49(10):748-757. PubMed ID: 28631944 [TBL] [Abstract][Full Text] [Related]
3. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation. Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022 [TBL] [Abstract][Full Text] [Related]
4. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia. Alali M; Mayampurath A; Dai Y; Bartlett AH Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855 [TBL] [Abstract][Full Text] [Related]
5. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis. Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study. Metais A; Torregrosa Diaz JM; Gallego Hernanz MP; Pichon M; Desmier D; Roblot F; Rammaert B J Infect; 2022 Jan; 84(1):1-7. PubMed ID: 34715238 [TBL] [Abstract][Full Text] [Related]
7. c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia. Kubo H; Imataki O; Kubo YH; Uemura M PLoS One; 2022; 17(3):e0263623. PubMed ID: 35298471 [TBL] [Abstract][Full Text] [Related]
8. c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia. Kubo H; Imataki O; Kubo YH; Uemura M; Kadowaki N Int J Clin Oncol; 2019 May; 24(5):590-595. PubMed ID: 30604157 [TBL] [Abstract][Full Text] [Related]
9. Early detection of infectious complications during induction therapy for acute leukemia with serial C-reactive protein biomarker assessment. Shimony S; Rozovski U; Sudry N; Yeshurun M; Yahav D; Raanani P; Wolach O Leuk Lymphoma; 2020 Nov; 61(11):2708-2713. PubMed ID: 32578463 [TBL] [Abstract][Full Text] [Related]
10. Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C-reactive protein, and blood culture findings. Lappalainen M; Hämäläinen S; Romppanen T; Pulkki K; Pyörälä M; Koivula I; Jantunen E; Juutilainen A Eur J Haematol; 2020 Dec; 105(6):731-740. PubMed ID: 32740997 [TBL] [Abstract][Full Text] [Related]
11. Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia. Soga Y; Yamasuji Y; Kudo C; Matsuura-Yoshimoto K; Yamabe K; Sugiura Y; Maeda Y; Ishimaru F; Tanimoto M; Nishimura F; Takashiba S Support Care Cancer; 2009 May; 17(5):581-7. PubMed ID: 19015893 [TBL] [Abstract][Full Text] [Related]
12. Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation. Kameda K; Kimura SI; Misaki Y; Yoshimura K; Gomyo A; Hayakawa J; Tamaki M; Kusuda M; Akahoshi Y; Ugai T; Ishihara Y; Kawamura K; Sakamoto K; Tanihara A; Wada H; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y Bone Marrow Transplant; 2019 May; 54(5):707-716. PubMed ID: 30171223 [TBL] [Abstract][Full Text] [Related]
13. Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Passweg JR; Labopin M; Christopeit M; Cornelissen J; Pabst T; Socié G; Russel N; Yakoub-Agha I; Blaise D; Gedde-Dahl T; Labussière-Wallet H; Malladi R; Forcade E; Maury S; Polge E; Lanza F; Gorin NC; Mohty M; Nagler A Biol Blood Marrow Transplant; 2020 Apr; 26(4):659-664. PubMed ID: 31759159 [TBL] [Abstract][Full Text] [Related]
14. Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study. Okamoto A; Kanda Y; Kimura SI; Oyake T; Tamura K; Int J Hematol; 2021 Oct; 114(4):472-482. PubMed ID: 34170481 [TBL] [Abstract][Full Text] [Related]
15. Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission. Usuki K; Kurosawa S; Uchida N; Yakushiji K; Waki F; Matsuishi E; Kagawa K; Furukawa T; Maeda Y; Shimoyama M; Ago H; Yamano Y; Yano S; Fujishima N; Takamatsu Y; Eto T; Hidaka M; Matsuoka H; Fukuda T Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):444-51. PubMed ID: 22999942 [TBL] [Abstract][Full Text] [Related]
16. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506 [TBL] [Abstract][Full Text] [Related]
17. Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia. Erbaş İC; Çakıl Güzin A; Özdem Alataş Ş; Karaoğlu Asrak H; Akans İ; Akyol Ş; Özlü C; Tüfekçi Ö; Yılmaz Ş; Ören H; Belet N Turk J Haematol; 2023 Aug; 40(3):143-153. PubMed ID: 37525503 [TBL] [Abstract][Full Text] [Related]
18. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study. Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C; Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202 [TBL] [Abstract][Full Text] [Related]
19. Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients? Massaro KS; Macedo R; de Castro BS; Dulley F; Oliveira MS; Yasuda MA; Levin AS; Costa SF Infection; 2014 Dec; 42(6):1023-32. PubMed ID: 25263811 [TBL] [Abstract][Full Text] [Related]
20. Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation? Yoon JH; Kim HJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS Biol Blood Marrow Transplant; 2017 Apr; 23(4):588-597. PubMed ID: 28089879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]